We are live on
!
Find out more
Vanguard Global Advisers Portfolio holdings
AUM
$215B
This Fund
S&P 500
This Quarter
Est. Return
-1.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$187B
AUM Growth
–
Cap. Flow
+$194B
Cap. Flow
% of AUM
104.07%
Top 10 Holdings %
Top 10 Hldgs %
40.78%
Holding
3,683
New
3,683
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$12.4B |
| 3 |
NVIDIA
NVDA
|
+$9.74B |
| 4 |
Apple
AAPL
|
+$8.35B |
| 5 |
Microsoft
MSFT
|
+$6.8B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.86% |
| 2 | Financials | 11.48% |
| 3 | Communication Services | 7.14% |
| 4 | Consumer Discretionary | 7.01% |
| 5 | Healthcare | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Nkarta
NKTX
$167M
| $38.2K | ﹤0.01% |
+18,095
| New | +$40.5K |
|
|
GPMT
3127
Granite Point Mortgage Trust
GPMT
$57.4M
| $38.2K | ﹤0.01% |
+26,316
| New | +$50.7K |
|
3128
ECB Bancorp
ECBK
$181M
| $38.1K | ﹤0.01% |
+2,279
| New | +$39.5K |
|
|
SGMO
3129
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $38.1K | ﹤0.01% |
+154,061
| New | +$61.3K |
|
3130
Agilon Health
AGL
$1.63B
| $37.8K | ﹤0.01% |
+4,785
| New | +$77.4K |
|
3131
GoPro
GPRO
$110M
| $37.5K | ﹤0.01% |
+48,673
| New | +$48.9K |
|
3132
DMC Global
BOOM
$155M
| $37.4K | ﹤0.01% |
+7,171
| New | +$50K |
|
3133
Inseego
INSG
$77M
| $37.3K | ﹤0.01% |
+3,358
| New | +$37.8K |
|
3134
MIND Technology
MIND
$43M
| $37K | ﹤0.01% |
+4,430
| New | +$38.7K |
|
3135
Fate Therapeutics
FATE
$308M
| $36.9K | ﹤0.01% |
+30,767
| New | +$37.5K |
|
|
SFBC
3136
Sound Financial Bancorp
SFBC
$119M
| $36.5K | ﹤0.01% |
+835
| New | +$36.2K |
|
3137
SKYX Platforms
SKYX
$152M
| $36.5K | ﹤0.01% |
+32,573
| New | +$68K |
|
|
BZAI
3138
Blaize Holdings
BZAI
$85.9M
| $36.3K | ﹤0.01% |
+19,947
| New | +$29.4K |
|
3139
Avita Medical
RCEL
$243M
| $36K | ﹤0.01% |
+9,734
| New | +$40.9K |
|
|
OMDA
3140
Omada Health Inc
OMDA
$1.46B
| $35.9K | ﹤0.01% |
+2,859
| New | +$39.5K |
|
|
TBI
3141
Trueblue
TBI
$311M
| $35.8K | ﹤0.01% |
+9,151
| New | +$40.6K |
|
|
SBC
3142
SBC Medical Group
SBC
$375M
| $35.8K | ﹤0.01% |
+8,557
| New | +$35.7K |
|
3143
Gain Therapeutics
GANX
$90.4M
| $35.6K | ﹤0.01% |
+18,376
| New | +$40K |
|
3144
Superior Group of Companies
SGC
$208M
| $35.6K | ﹤0.01% |
+3,508
| New | +$35.3K |
|
|
FSP
3145
Franklin Street Properties
FSP
$50.8M
| $35.6K | ﹤0.01% |
+53,551
| New | +$41.4K |
|
3146
Comtech Telecommunications
CMTL
$52.7M
| $35.6K | ﹤0.01% |
+10,726
| New | +$55.2K |
|
3147
Arq
ARQ
$102M
| $35.6K | ﹤0.01% |
+13,907
| New | +$44.5K |
|
3148
Adicet Bio
ACET
$78.4M
| $35.6K | ﹤0.01% |
+5,221
| New | +$39.1K |
|
3149
SelectQuote
SLQT
$129M
| $35.5K | ﹤0.01% |
+56,402
| New | +$59.2K |
|
3150
Crexendo
CXDO
$221M
| $35.5K | ﹤0.01% |
+5,754
| New | +$37.8K |
|
Similar funds
Vanguard Global Advisers's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Global Advisers, which disclosed 3,683 positions worth $187B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Communication Services.
- Vanguard Global Advisers's largest Q1 2026 buy was Vanguard S&P 500 ETF: 39,600,312 shares worth $23.7B.
- Vanguard Global Advisers's ten largest holdings make up 41% of its $187B portfolio in Q1 2026.
- Vanguard Global Advisers disclosed 3,683 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.